The February Journal Club focused on the recent paper “Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances”. Hosted by Dr. Oliver Medvedik, we were joined by study author Dr. Peter Joshi from the University of Edinburgh, UK, who guides us through this fascinating genomics study of human longevity. We would like to thank Peter for taking the time to join us and talk us through the study.
Oliver Medvedik, Co-founder of Genspace citizen science laboratory in Brooklyn NY, earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. As part of his doctoral work he has used single-celled budding yeast as a model system to map the genetic pathways that underlie the processes of aging in more complex organisms, such as humans.
Prior to arriving in Boston for his doctoral studies, he has lived most of his life in New York City. He obtained his bachelor’s degree in biology from Hunter College, City University of New York. Since graduating from Harvard, he has worked as a biotechnology consultant, taught molecular biology to numerous undergraduates at Harvard University and mentored two of Harvard’s teams for the international genetically engineered machines competition (IGEM) held annually at M.I.T.
Oliver is also the Director of The Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, New York City. The Maurice Kanbar Center for Biomedical Engineering is open to all Cooper Union faculty and students working on bioengineering projects requiring equipment and space for tissue culture, genetic engineering, biomechanics, and related research. Faculty that is currently using the facility are pursuing groundbreaking biomedical research in such fields as biomedical devices, tissue engineering, obstructive sleep apnea biomechanics also collaborating with several major New York City-based hospitals. The Kanbar Center continues to provide space for undergraduate teams participating in the international genetically engineered competition (iGEM) during the summer, as well as space for courses that offer a biological laboratory component.
Can anyone of you explain how this Spooky2 Scalar works where people are using it to heal chronic conditions like cancer are seeing a reverse aging effect. Not only are they witnessing cancer tumors shrinking, but they are reporting their grey hair being restored to brown hair. I’m really curious what this Spooky2 Scalar is doing to the body other than help people sleep that is causing a reverse aging effect and thought your group may already have the answer.
Journal Club returns on Tuesday, April 26th at noon Eastern time on our Facebook page. Dr. Oliver Medvedik will be taking a look at the recent paper […]
On Tuesday, March 29th, the Journal Club will be livestreamed to our Facebook page at 12:00 Eastern. Dr. Oliver Medvedik will be taking a look at a new paper showing that partial cellular reprogramming to reverse cellular aging in […]
The next Journal Club will be on Tuesday 2nd November and Dr. Oliver Medvedik will be taking a look at a new paper called “Targeted clearance of senescent cells using an antibody-drug conjugate […]
Journal Club returns on July 27th at noon Eastern / 17:00 UK live on our Facebook page. A new way to look at Alzheimer’s The topic for this month will be a new study that challenges the […]
Journal Club returns live to our Facebook channel on June 29th at noon Eastern Time with Dr. Oliver Medvedik. This month, we are taking a look at rapamycin, a drug that has long been believed […]
1 Comment
David Crawford
April 12, 2019
Can anyone of you explain how this Spooky2 Scalar works where people are using it to heal chronic conditions like cancer are seeing a reverse aging effect. Not only are they witnessing cancer tumors shrinking, but they are reporting their grey hair being restored to brown hair. I’m really curious what this Spooky2 Scalar is doing to the body other than help people sleep that is causing a reverse aging effect and thought your group may already have the answer.
Write a comment: